InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,528.93
(
-2.12%
)
US TECH 100
18,420.40
(
-3.31%
)
Dow Jones
40,936.93
(
-1.51%
)
Brent Oil
73.37
(
-0.35%
)
Bitcoin
56,290.70
(
-1.96%
)
Post# of 977
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jondoeuk

Send PM Follow Ignore
Followers 33
Posts 2853
Boards Moderated 1
Alias Born 10/24/2015

jondoeuk

Re: None

Sunday, 07/11/2021 1:27:04 PM

Sunday, July 11, 2021 1:27:04 PM

Post# of 977
The company has dosed the first R/R AML patient with 622, in combination with azacitidine and venetoclax. This is being assessed as part of an ongoing, open-label trial. Around fifty elderly patients (at least 75 years old) or patients unfit for intensive induction chemo will be enrolled. The primary endpoints are safety and CR rate.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM

UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM

Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM

Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM

ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM

North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!